Logo
x

Search

Subscribe Now

Monotherapy

AbbVie Reports Results of Rinvoq (upadacitinib) as Monotherapy in a P-III Measure Up 2 Study for Atopic Dermatitis

AbbVie Reports Results of Rinvoq (upadacitinib) as Monotherapy in a P-III Measure Up 2 Study for Atopic Dermatitis

  • July 22, 2020
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as Monotherapy for Patients with Unresectable or Metastatic Tumor Mutational Burden-High Solid Tumors

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as Monotherapy for Patients with Unresectable or Metastatic Tumor...

  • June 18, 2020
Roche's Tecentriq Receives the US FDA's Approval as 1L Monotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Roche's Tecentriq Receives the US FDA's Approval as 1L Monotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

  • May 19, 2020
GSK's Zejula (niraparib) Receives the US FDA's Approval as 1L Monotherapy Maintenance Treatment for Women with Advanced Ovarian Cancer Regardless of Biomarker Status

GSK's Zejula (niraparib) Receives the US FDA's Approval as 1L Monotherapy Maintenance Treatment for Women with Advanced Ovarian Ca...

  • April 30, 2020
Roche Reports the US FDA Acceptance of sBLA and Granted Priority Review for Tecentriq (atezolizumab) as 1L Monotherapy for Advanced Non-Small Cell Lung Cancer

Roche Reports the US FDA Acceptance of sBLA and Granted Priority Review for Tecentriq (atezolizumab) as 1L Monotherapy for Advance...

  • February 19, 2020
Astellas' Xospata (gilteritinib) Receives EC's Approval as Monotherapy for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Astellas' Xospata (gilteritinib) Receives EC's Approval as Monotherapy for Relapsed or Refractory Acute Myeloid Leukemia with a FL...

  • October 25, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.